top of page
Research progress
Mihkal GmbH LM4514 RGB 05072021 richtige Farben.jpg

New Patent Applications and Research Progress

08. October 2026

Since our last news update  we have continued our research into novel compounds and prodrugs. New international patent applications, publications in Europe and the United States, and scientific papers involving MiHKAL reflect this work. Several patents have also been granted for the psilocin prodrugs developed by Matthias Grill.

PCT Patent Application published

PCT DMT

13. June 2024

Applicant: MiHKAL GmbH

​

​WO2024121253 - Novel N,N-Dimethyltryptamine (DMT) Derivatives And Uses Thereof

Phenethylamine

PCT Patent Application published

21. March 2024

image.png

Inventor: Dr. Matthias Grill

​

​WO2024056678 - Novel nootropic prodrugs of Phenethylamine 

Lykos Therapeutics Secures $100 Million Funding Boost

Lykos
dollars-499481.jpg

07. January 2024

Funding highlights the broader recognition of psychedelic therapies 

reaquire
Mihkal GmbH LM4514 RGB 05072021 richtige Farben.jpg

MiHKAL Reacquires Patents from COMPASS Pathfinder

A Milestone for Psychedelic Research and Therapy

08. September 2023

Bicycle day

Bicycle Day 2023 

bicycle-1869432.jpg

Tracing Back the Footsteps of Albert Hofmann

17.April 2023

Australia
head-4653696.jpg

Australia Approves MDMA and Psilocybin for Mental Health Treatment

07. April 2023

Wiley
WILEY.JPG

WILEY recognizes one of the most downloaded publications in Drug testing and analysis 

31.March 2023

Drogenstadt
Zeitungsartikel Bild.JPG

MiHKAL in the newspaper

20. May 2022

Drogenstadt Basel 

mdma-prodrug-logo.png

PCT Patent Application published

17. March 2022

Safrylamine

Inventor: Dr. Matthias Grill

​

​WO2022053696 - Novel Safrylamine derivates having prodrug properties

Video interview
compass-logo-news.png

Video Interview with Dr. Matthias Grill

09. March 2022

In a video Interview, Dr. Matthias Grill is talking about MiHKAL and the collaboration with COMPASS  

Annual report
compass-logo-news.png

MiHKAL highlighted in annual report of COMPASS Pathways

24. February 2022

COMPASS pathways announces financial results for the year 2021 and is highlighting the pipeline development with MiHKAL GmbH

Psilocin
Psylocin.png

PCT Patent Application published

24. February 2022

Inventor: Dr. Matthias Grill

​

W02022038299 - Novel Psilocin derivates having prodrug properties

Tagesanzeiger
Unbenannt.JPG

MiHKAL in the Newspaper "Tagesanzeiger"

02. February 2022

Mit Partydrogen gegen Depression

LSD
LSD.png

PCT Patent Application published

13. January 2022

Inventor: Dr. Matthias Grill

​

W02022008627 - Improved method for the production of lysergic acid diethylamide (LSD) and novel derivatives thereof

Collaboration
compass-logo-news.png

Collaboration with Compass Pathways

14. September 2021

COMPASS Pathways has acquired an intellectual property portfolio from MiHKAL, who will be working with COMPASS on an exclusive research project to develop new product candidates.

Foundation
Mihkal GmbH LM4514 RGB 05072021 richtige Farben.jpg

Foundation of MiHKAL

22. March 2021

MiHKAL is founded

bottom of page